CTAC NV (CTAC.AS) Fundamental Analysis & Valuation

AMS:CTAC • NL0000345577

Current stock price

2.9 EUR
+0.03 (+1.05%)
Last:

This CTAC.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. CTAC.AS Profitability Analysis

1.1 Basic Checks

  • CTAC had positive earnings in the past year.
  • In the past year CTAC had a positive cash flow from operations.
  • CTAC had positive earnings in each of the past 5 years.
  • CTAC had a positive operating cash flow in each of the past 5 years.
CTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFCTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 8.12%, CTAC belongs to the top of the industry, outperforming 83.10% of the companies in the same industry.
  • CTAC has a better Return On Equity (18.91%) than 74.65% of its industry peers.
  • CTAC has a Return On Invested Capital (6.91%) which is comparable to the rest of the industry.
  • The Average Return On Invested Capital over the past 3 years for CTAC is below the industry average of 11.27%.
Industry RankSector Rank
ROA 8.12%
ROE 18.91%
ROIC 6.91%
ROA(3y)4.34%
ROA(5y)4.75%
ROE(3y)10.63%
ROE(5y)12.49%
ROIC(3y)7.76%
ROIC(5y)7.73%
CTAC.AS Yearly ROA, ROE, ROICCTAC.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 3.10%, CTAC is in line with its industry, outperforming 49.30% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CTAC has grown nicely.
  • CTAC has a Operating Margin of 2.97%. This is in the lower half of the industry: CTAC underperforms 70.42% of its industry peers.
  • CTAC's Operating Margin has improved in the last couple of years.
  • CTAC's Gross Margin of 37.21% is on the low side compared to the rest of the industry. CTAC is outperformed by 66.20% of its industry peers.
  • In the last couple of years the Gross Margin of CTAC has declined.
Industry RankSector Rank
OM 2.97%
PM (TTM) 3.1%
GM 37.21%
OM growth 3Y-9.71%
OM growth 5Y12.14%
PM growth 3Y-9.09%
PM growth 5Y15.3%
GM growth 3Y-5.24%
GM growth 5Y-3.9%
CTAC.AS Yearly Profit, Operating, Gross MarginsCTAC.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CTAC.AS Health Analysis

2.1 Basic Checks

  • CTAC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • CTAC has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, CTAC has more shares outstanding
  • Compared to 1 year ago, CTAC has an improved debt to assets ratio.
CTAC.AS Yearly Shares OutstandingCTAC.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
CTAC.AS Yearly Total Debt VS Total AssetsCTAC.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • CTAC has an Altman-Z score of 3.79. This indicates that CTAC is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.79, CTAC belongs to the top of the industry, outperforming 81.69% of the companies in the same industry.
  • A Debt/Equity ratio of 0.37 indicates that CTAC is not too dependend on debt financing.
  • CTAC has a better Debt to Equity ratio (0.37) than 60.56% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Altman-Z 3.79
ROIC/WACC1.07
WACC6.46%
CTAC.AS Yearly LT Debt VS Equity VS FCFCTAC.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 1.00 indicates that CTAC should not have too much problems paying its short term obligations.
  • CTAC's Current ratio of 1.00 is on the low side compared to the rest of the industry. CTAC is outperformed by 64.79% of its industry peers.
  • CTAC has a Quick Ratio of 1.00. This is a normal value and indicates that CTAC is financially healthy and should not expect problems in meeting its short term obligations.
  • CTAC has a Quick ratio (1.00) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 1
CTAC.AS Yearly Current Assets VS Current LiabilitesCTAC.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. CTAC.AS Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 308.73% over the past year.
  • Measured over the past years, CTAC shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.20% on average per year.
  • The Revenue has decreased by -2.28% in the past year.
  • CTAC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.74% yearly.
EPS 1Y (TTM)308.73%
EPS 3Y-5.51%
EPS 5Y24.2%
EPS Q2Q%N/A
Revenue 1Y (TTM)-2.28%
Revenue growth 3Y5.32%
Revenue growth 5Y8.74%
Sales Q2Q%3.33%

3.2 Future

  • CTAC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.39% yearly.
  • Based on estimates for the next years, CTAC will show a small growth in Revenue. The Revenue will grow by 7.12% on average per year.
EPS Next Y14.29%
EPS Next 2Y15.18%
EPS Next 3Y9.88%
EPS Next 5Y3.39%
Revenue Next Year2.42%
Revenue Next 2Y3.37%
Revenue Next 3Y3.63%
Revenue Next 5Y7.12%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CTAC.AS Yearly Revenue VS EstimatesCTAC.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M
CTAC.AS Yearly EPS VS EstimatesCTAC.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.1 0.2 0.3

More info and screens

Find the best growth stocksShow best growing peers

6

4. CTAC.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • CTAC is valuated reasonably with a Price/Earnings ratio of 10.36.
  • 88.73% of the companies in the same industry are more expensive than CTAC, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 25.79, CTAC is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 8.75, the valuation of CTAC can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, CTAC is valued cheaply inside the industry as 80.28% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.80, CTAC is valued rather cheaply.
Industry RankSector Rank
PE 10.36
Fwd PE 8.75
CTAC.AS Price Earnings VS Forward Price EarningsCTAC.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CTAC indicates a rather cheap valuation: CTAC is cheaper than 85.92% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.28
CTAC.AS Per share dataCTAC.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • CTAC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.73
PEG (5Y)0.43
EPS Next 2Y15.18%
EPS Next 3Y9.88%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. CTAC.AS Dividend Analysis

5.1 Amount

  • CTAC has a Yearly Dividend Yield of 3.74%. Purely for dividend investing, there may be better candidates out there.
  • CTAC's Dividend Yield is a higher than the industry average which is at 2.88.
  • CTAC's Dividend Yield is rather good when compared to the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 3.74%

5.2 History

  • The dividend of CTAC is nicely growing with an annual growth rate of 17.13%!
Dividend Growth(5Y)17.13%
Div Incr Years0
Div Non Decr Years1
CTAC.AS Yearly Dividends per shareCTAC.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

  • 26.79% of the earnings are spent on dividend by CTAC. This is a low number and sustainable payout ratio.
  • The dividend of CTAC is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP26.79%
EPS Next 2Y15.18%
EPS Next 3Y9.88%
CTAC.AS Yearly Income VS Free CF VS DividendCTAC.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
CTAC.AS Dividend Payout.CTAC.AS Dividend Payout, showing the Payout Ratio.CTAC.AS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CTAC.AS Fundamentals: All Metrics, Ratios and Statistics

CTAC NV

AMS:CTAC (3/17/2026, 7:00:00 PM)

2.9

+0.03 (+1.05%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners5.23%
Inst Owner ChangeN/A
Ins Owners22.27%
Ins Owner ChangeN/A
Market Cap41.03M
Revenue(TTM)188.22M
Net Income(TTM)5.81M
Analysts80
Price Target2.87 (-1.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.74%
Yearly Dividend0.11
Dividend Growth(5Y)17.13%
DP26.79%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.44%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-22.22%
EPS NY rev (3m)-22.22%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-4.51%
Revenue NY rev (3m)-4.51%
Valuation
Industry RankSector Rank
PE 10.36
Fwd PE 8.75
P/S 0.22
P/FCF N/A
P/OCF 19.87
P/B 1.34
P/tB 9.61
EV/EBITDA 4.28
EPS(TTM)0.28
EY9.66%
EPS(NY)0.33
Fwd EY11.43%
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)0.15
OCFY5.03%
SpS13.23
BVpS2.17
TBVpS0.3
PEG (NY)0.73
PEG (5Y)0.43
Graham Number3.7
Profitability
Industry RankSector Rank
ROA 8.12%
ROE 18.91%
ROCE 14.87%
ROIC 6.91%
ROICexc 7.31%
ROICexgc 20.83%
OM 2.97%
PM (TTM) 3.1%
GM 37.21%
FCFM N/A
ROA(3y)4.34%
ROA(5y)4.75%
ROE(3y)10.63%
ROE(5y)12.49%
ROIC(3y)7.76%
ROIC(5y)7.73%
ROICexc(3y)9.86%
ROICexc(5y)10.11%
ROICexgc(3y)93.05%
ROICexgc(5y)116.82%
ROCE(3y)14.76%
ROCE(5y)14.73%
ROICexgc growth 3Y-10.84%
ROICexgc growth 5Y39.25%
ROICexc growth 3Y-2.56%
ROICexc growth 5Y15.11%
OM growth 3Y-9.71%
OM growth 5Y12.14%
PM growth 3Y-9.09%
PM growth 5Y15.3%
GM growth 3Y-5.24%
GM growth 5Y-3.9%
F-Score6
Asset Turnover2.62
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Debt/EBITDA 1.03
Cap/Depr 69.48%
Cap/Sales 1.99%
Interest Coverage 14.1
Cash Conversion 18.91%
Profit Quality N/A
Current Ratio 1
Quick Ratio 1
Altman-Z 3.79
F-Score6
WACC6.46%
ROIC/WACC1.07
Cap/Depr(3y)40.73%
Cap/Depr(5y)30.86%
Cap/Sales(3y)1.72%
Cap/Sales(5y)1.4%
Profit Quality(3y)401.58%
Profit Quality(5y)373.89%
High Growth Momentum
Growth
EPS 1Y (TTM)308.73%
EPS 3Y-5.51%
EPS 5Y24.2%
EPS Q2Q%N/A
EPS Next Y14.29%
EPS Next 2Y15.18%
EPS Next 3Y9.88%
EPS Next 5Y3.39%
Revenue 1Y (TTM)-2.28%
Revenue growth 3Y5.32%
Revenue growth 5Y8.74%
Sales Q2Q%3.33%
Revenue Next Year2.42%
Revenue Next 2Y3.37%
Revenue Next 3Y3.63%
Revenue Next 5Y7.12%
EBIT growth 1Y12.01%
EBIT growth 3Y-4.9%
EBIT growth 5Y21.94%
EBIT Next Year46.67%
EBIT Next 3Y16.96%
EBIT Next 5Y12.47%
FCF growth 1Y-117.49%
FCF growth 3Y-7.01%
FCF growth 5Y0.39%
OCF growth 1Y-81.98%
OCF growth 3Y2.52%
OCF growth 5Y4.91%

CTAC NV / CTAC.AS Fundamental Analysis FAQ

What is the fundamental rating for CTAC stock?

ChartMill assigns a fundamental rating of 5 / 10 to CTAC.AS.


Can you provide the valuation status for CTAC NV?

ChartMill assigns a valuation rating of 6 / 10 to CTAC NV (CTAC.AS). This can be considered as Fairly Valued.


Can you provide the profitability details for CTAC NV?

CTAC NV (CTAC.AS) has a profitability rating of 5 / 10.


What is the financial health of CTAC NV (CTAC.AS) stock?

The financial health rating of CTAC NV (CTAC.AS) is 5 / 10.


Can you provide the dividend sustainability for CTAC stock?

The dividend rating of CTAC NV (CTAC.AS) is 6 / 10 and the dividend payout ratio is 26.79%.